Along the same line, tumor growth and weight in mice were significantly reduced in PDAC xenografts as well as in PDAC patient-derived xenograft mice models after treatment with RN1—a polysaccharide Gal3 inhibitor—as compared to vehicle-treated mice [80]. The gene discussed is LGALS3; the disease is neoplasm.